Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 5, 2024CureusOpen Access

A Case Report of Concurrent Epidermal Growth Factor Receptor (EGFR) Exon 18 (G719A) and Exon 21 (L833V834delinsFL) Mutations and Treatment Challenges

View Full Paper
Ask AI
Bookmark
Share

Authors

MHMuhammad Delwar HussainUniversity of Maryland Eastern ShoreNMNicholas MackridesTemple University Health SystemSSStacey Su

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hussain et al. (2024) studied this question.

synapsesocial.com/papers/68e55c81e2b3180350ef9beehttps://doi.org/10.7759/cureus.70896
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma2009 · 8,326 citations
  2. 2A single digital droplet PCR assay to detect multipleKITexon 11 mutations in tumor and plasma from patients with gastrointestinal stromal tumors2018 · 35 citations
  3. 3Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib2004 · 11,596 citations
  4. 4Efficacy analysis of tyrosine kinase inhibitors on rare non-small cell lung cancer patients harboring complex EGFR mutations2014 · 48 citations